Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases
Phase of Trial: Phase IV
Latest Information Update: 15 Dec 2017
At a glance
- Drugs Radium 223 chloride (Primary)
- Indications Bone metastases; Prostate cancer
- Focus Adverse reactions
- Sponsors Bayer
- 01 Sep 2016 Status changed from not yet recruiting to recruiting.
- 26 Jul 2016 Planned initiation date changed from 1 Jun 2016 to 1 Aug 2016.
- 21 Jun 2016 New trial record